In ZS’s survey of Canadian pharmaceutical companies, we uncovered their plans to more fully use patient support program data, real-world evidence and artificial intelligence/advanced analytics to help improve health outcomes. Here’s a look at the initiatives they plan to implement in the next 24 months.